S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

Qilian International Holding Group (QLI) Competitors

$0.49
+0.07 (+16.83%)
(As of 03/1/2024 ET)

QLI vs. ADCT, GHRS, GRFS, LVTX, MYNZ, NLSP, PROC, SIOX, ATNFW, and SXTPW

Should you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include ADC Therapeutics (ADCT), GH Research (GHRS), Grifols (GRFS), LAVA Therapeutics (LVTX), Mainz Biomed (MYNZ), NLS Pharmaceutics (NLSP), Procaps Group (PROC), Sio Gene Therapies (SIOX), 180 Life Sciences (ATNFW), and 60 Degrees Pharmaceuticals (SXTPW). These companies are all part of the "medical" sector.

Qilian International Holding Group vs.

Qilian International Holding Group (NASDAQ:QLI) and ADC Therapeutics (NYSE:ADCT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.

Qilian International Holding Group has higher earnings, but lower revenue than ADC Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Qilian International Holding Group$46.47MN/A-$7.78MN/AN/A
ADC Therapeutics$209.91MN/A-$155.80M-$2.20-2.21

Qilian International Holding Group has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, ADC Therapeutics has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500.

67.3% of ADC Therapeutics shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by insiders. Comparatively, 35.4% of ADC Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Qilian International Holding Group has a net margin of 0.00% compared to ADC Therapeutics' net margin of -145.64%. Qilian International Holding Group's return on equity of 0.00% beat ADC Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Qilian International Holding GroupN/A N/A N/A
ADC Therapeutics -145.64%-1,121.94%-36.23%

ADC Therapeutics has a consensus target price of $6.33, suggesting a potential upside of 30.32%. Given ADC Therapeutics' higher probable upside, analysts clearly believe ADC Therapeutics is more favorable than Qilian International Holding Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Qilian International Holding Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ADC Therapeutics
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

In the previous week, ADC Therapeutics had 2 more articles in the media than Qilian International Holding Group. MarketBeat recorded 5 mentions for ADC Therapeutics and 3 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 1.17 beat ADC Therapeutics' score of 0.32 indicating that Qilian International Holding Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Qilian International Holding Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ADC Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

ADC Therapeutics received 44 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. However, 100.00% of users gave Qilian International Holding Group an outperform vote while only 61.64% of users gave ADC Therapeutics an outperform vote.

CompanyUnderperformOutperform
Qilian International Holding GroupOutperform Votes
1
100.00%
Underperform Votes
No Votes
ADC TherapeuticsOutperform Votes
45
61.64%
Underperform Votes
28
38.36%

Summary

Qilian International Holding Group and ADC Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.


Get Qilian International Holding Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for QLI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QLI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QLI vs. The Competition

MetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$6.75B$5.11B$7.64B
Dividend YieldN/A2.83%2.82%3.87%
P/E RatioN/A7.29160.2313.31
Price / SalesN/A235.673,058.6877.08
Price / Cash7.5519.33100.6555.48
Price / Book0.324.654.534.53
Net Income-$7.78M$155.01M$115.01M$211.55M
7 Day Performance-19.07%7.79%5.72%3.36%
1 Month Performance-17.91%15.91%12.82%6.70%
1 Year Performance-64.00%8.07%12.94%7.44%

Qilian International Holding Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADCT
ADC Therapeutics
3.3783 of 5 stars
$5.01
-2.5%
$6.33
+26.4%
+48.6%$0.00$209.91M-2.28317Short Interest ↓
Gap Up
GHRS
GH Research
1.9569 of 5 stars
$8.72
+8.6%
$40.67
+366.4%
-16.0%$0.00N/A-11.0432Earnings Report
Upcoming Earnings
Analyst Report
News Coverage
GRFS
Grifols
3.8544 of 5 stars
$9.30
+0.1%
$10.50
+12.9%
-19.2%$0.00$6.39B0.0026,314News Coverage
LVTX
LAVA Therapeutics
3.0352 of 5 stars
$2.12
flat
$6.00
+183.0%
-4.3%$0.00$19.39M-1.1069Short Interest ↓
News Coverage
Gap Down
MYNZ
Mainz Biomed
3.4133 of 5 stars
$0.90
-5.3%
$7.00
+677.1%
-86.5%$0.00$530,000.000.0058Short Interest ↓
NLSP
NLS Pharmaceutics
0 of 5 stars
$0.39
-2.5%
N/A-75.2%$0.00N/A0.006
PROC
Procaps Group
3.7531 of 5 stars
$3.06
-1.6%
$4.50
+47.1%
-27.7%$0.00$409.92M5.885,500Short Interest ↓
SIOX
Sio Gene Therapies
0 of 5 stars
$0.48
+1.7%
N/A+16.3%$0.00N/A0.0012Gap Down
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-80.0%$0.00N/A0.005Short Interest ↑
Gap Down
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.13
flat
N/AN/A$0.00$90,718.000.002

Related Companies and Tools

This page (NASDAQ:QLI) was last updated on 3/3/2024 by MarketBeat.com Staff